View this Q&A below from University of Chicago Medicine experts Dr. Michael O’Connor and Dr. Thomas Spiegel as they touch on the latest on COVID-19 treatments and outcomes.
Source: University of Chicago Medicine
Categories
What’s New
- Sex Differences in Various Aspects of Transthyretin Cardiac Amyloidosis
- ATTR-CA Prevalence and Screening in Transcatheter Aortic Valve Replacement Population
- Effects of Tafamidis on Patients With Ala97Ser Hereditary Transthyretin Cardiomyopathy
- Oatmeal Cream (1%) for Mild-to-Moderate Atopic Dermatitis in Black Children
- Dupilumab Prescription Patterns for Atopic Dermatitis in Adults
- Evaluating Racial/Ethnic Disparities in Atopic Dermatitis Severity and Treatment
- The Role of Air Pollution in Atopic Dermatitis
- AAAAI Reports on Systemic Racism and Allergic Diseases
- Intensity-Modulated Radiation Therapy Best for Locally Advanced NSCLC
- Tobacco, Cannabis Use Tied to High Rates of Self-Reported Mental Health Issues